| 110.05 1.2 (1.1%) | 12-12 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 131.36 | 1-year : | 135.3 |
| Resists | First : | 112.46 | Second : | 115.83 |
| Pivot price | 109.46 |
|||
| Supports | First : | 107.01 | Second : | 89.03 |
| MAs | MA(5) : | 108.42 |
MA(20) : | 110.01 |
| MA(100) : | 108.07 |
MA(250) : | 0 | |
| MACD | MACD : | -0.6 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 30.7 |
D(3) : | 16.9 |
| RSI | RSI(14): 51.3 |
|||
| 52-week | High : | 115.83 | Low : | 96.94 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AFL ] has closed below upper band by 37.4%. Bollinger Bands are 32.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 110.37 - 110.89 | 110.89 - 111.37 |
| Low: | 107.86 - 108.49 | 108.49 - 109.06 |
| Close: | 109.03 - 110.05 | 110.05 - 110.97 |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Fri, 12 Dec 2025
Occudo Quantitative Strategies LP Takes $3.88 Million Position in Aflac Incorporated $AFL - MarketBeat
Fri, 12 Dec 2025
CIBC Asset Management Inc Increases Stake in Aflac Incorporated $AFL - MarketBeat
Thu, 11 Dec 2025
Aflac Incorporated's (NYSE:AFL) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
Thu, 11 Dec 2025
Axa S.A. Decreases Stock Position in Aflac Incorporated $AFL - MarketBeat
Tue, 09 Dec 2025
Insider Sell Alert: Steven Beaver Sells Shares of Aflac Inc - GuruFocus
Tue, 09 Dec 2025
Aflac Incorporated $AFL Stock Position Decreased by Ossiam - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Insurance - Life
|
|
| Shares Out | 524 (M) |
| Shares Float | 520 (M) |
| Held by Insiders | 10.7 (%) |
| Held by Institutions | 58.9 (%) |
| Shares Short | 6,970 (K) |
| Shares Short P.Month | 6,330 (K) |
| EPS | 7.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 54.56 |
| Profit Margin | 23.5 % |
| Operating Margin | 43.2 % |
| Return on Assets (ttm) | 2.6 % |
| Return on Equity (ttm) | 15.5 % |
| Qtrly Rev. Growth | 60.7 % |
| Gross Profit (p.s.) | 16.27 |
| Sales Per Share | 33.77 |
| EBITDA (p.s.) | 10.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 2,570 (M) |
| Levered Free Cash Flow | 6,490 (M) |
| PE Ratio | 14.46 |
| PEG Ratio | 0 |
| Price to Book value | 2.01 |
| Price to Sales | 3.25 |
| Price to Cash Flow | 22.44 |
| Dividend | 0.57 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|